(2022) Predicting efficacy of 5-fluorouracil therapy via a mathematical model with fuzzy uncertain parameters. J Med Signals Sens. pp. 202-218. ISSN 22287477 (ISSN)
Full text not available from this repository.
Abstract
Background: Due to imprecise/missing data used for parameterization of ordinary differential equations (ODEs), model parameters are uncertain. Uncertainty of parameters has hindered the application of ODEs that require accurate parameters. Methods: We extended an available ODE model of tumor-immune system interactions via fuzzy logic to illustrate the fuzzification procedure of an ODE model. The fuzzy ODE (FODE) model assigns a fuzzy number to the parameters, to capture parametric uncertainty. We used the FODE model to predict tumor and immune cell dynamics and to assess the efficacy of 5-fluorouracil (5-FU) chemotherapy. Result: FODE model investigates how parametric uncertainty affects the uncertainty band of cell dynamics in the presence and absence of 5-FU treatment. In silico experiments revealed that the frequent 5-FU injection created a beneficial tumor microenvironment that exerted detrimental effects on tumor cells by enhancing the infiltration of CD8+ T cells, and natural killer cells, and decreasing that of myeloid-derived suppressor cells. The global sensitivity analysis was proved model robustness against random perturbation to parameters. Conclusion: ODE models with fuzzy uncertain kinetic parameters cope with insufficient/imprecise experimental data in the field of mathematical oncology and can predict cell dynamics uncertainty band. © 2022 Journal of Medical Signals & Sensors.
Item Type: | Article |
---|---|
Keywords: | 5-fluorouracil fuzzy ordinary differential equation uncertain |
Page Range: | pp. 202-218 |
Journal or Publication Title: | J Med Signals Sens |
Journal Index: | Scopus |
Volume: | 12 |
Number: | 3 |
Identification Number: | https://doi.org/10.4103/jmss.jmss₉₂₂₁ |
ISSN: | 22287477 (ISSN) |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/16830 |
Actions (login required)
View Item |